DEFA14A: BlackRock Health Sciences Term Trust Faces Proxy Fight: Hedge Fund Seeks Board Control

BlackRock is urging shareholders of the Health Sciences Term Trust (BMEZ) to vote against a hedge fund's attempt to install its own board nominees, claiming it could harm long-term investment value.

Summary

• BlackRock is actively campaigning to protect the BlackRock Health Sciences Term Trust (BMEZ) from a takeover attempt by a self-interested hedge fund.
• The hedge fund, Saba, is seeking to install its own board nominees, which BlackRock argues could lead to underperformance, deeper discounts, and higher fees for shareholders.
• BlackRock highlights BMEZ's strong performance, including total shareholder returns of 8.8% from January 2023 to May 2024, outperforming the peer median of 3.8%.
• BMEZ has significantly narrowed its discount to NAV from 17.8% on December 31, 2022, to 12.6% on May 31, 2024.
• BlackRock has implemented a share buyback program, repurchasing $96 million in shares, resulting in $18 million in NAV accretion for shareholders.
• A discount management program is in place, potentially offering to repurchase 2.5% of outstanding common shares quarterly at 98% of NAV if the discount exceeds 7.5% during specific periods.
• Shareholders are urged to vote FOR BlackRock's Class II Board Member Nominees and AGAINST Saba's proposal to terminate the investment management agreement.
• BlackRock emphasizes the importance of voting using the WHITE proxy card and disregarding any gold proxy cards from Saba.

Sentiment

Score: 7

Explanation: The document conveys a sense of urgency and determination to defend shareholder value against a perceived threat. While highlighting positive performance metrics, the overall tone is defensive due to the ongoing proxy fight.

Positives

• BMEZ has outperformed its peers in terms of total shareholder returns.
• The discount to NAV has been significantly reduced.
• The share buyback program has increased NAV for shareholders.
• The discount management program aims to provide liquidity at NAV.

Negatives

• A hedge fund is attempting to take control of the board, which BlackRock believes could negatively impact shareholder value.
• The fund's shares still trade at a discount to NAV.

Risks

• The potential for a change in board control could lead to changes in investment strategy and management fees.
• The discount management program is contingent on the fund's shares trading at a discount of more than 7.5%.

Future Outlook

BlackRock intends to offer to repurchase 2.5% of its outstanding common shares at a price equal to 98% of NAV following the end of applicable quarters if the funds common shares trade at a discount of more than 7.5% during each of the quarters ended 6/30/24, 9/30/24, 12/31/24 and 3/31/25.

Management Comments

• Stephen Minar, Managing Director, Closed-End Funds: 'BlackRock is fighting to protect your fund, but we need your support.'
• Stephen Minar, Managing Director, Closed-End Funds: 'A self-interested hedge fund is attempting to install their own hand-picked Board nominees to BMEZs Board.'
• Stephen Minar, Managing Director, Closed-End Funds: 'Their goal? A quick profit at the expense of your long-term investment.'

Industry Context

Activist investors targeting closed-end funds is a recurring theme in the financial industry, as these funds often trade at discounts to their net asset value, creating opportunities for arbitrage and potential value unlocking through various strategies, including board control and fund restructuring.

Comparison to Industry Standards

• The document compares BMEZ's total shareholder return to the peer median of closed-end funds in the Morningstar Health category, indicating a benchmark for performance evaluation.
• The discount to NAV is a common metric used to assess the valuation of closed-end funds, and BMEZ's narrowing discount suggests improved market sentiment or active management efforts.
• Share buyback programs are a typical strategy employed by closed-end funds to reduce the discount to NAV and enhance shareholder value, aligning with industry practices.

Stakeholder Impact

• Shareholders are directly impacted by the outcome of the proxy vote, which could affect the fund's investment strategy and performance.
• BlackRock's reputation and management of the fund are at stake.
• The hedge fund's actions could influence the fund's future direction and shareholder returns.

Next Steps

• Shareholders are urged to vote using the WHITE proxy card.
• The annual meeting will be held on June 25.

Key Dates

Keywords

BlackRock, Health Sciences Term Trust, BMEZ, Proxy Fight, Saba, Hedge Fund, Board Nominees, Shareholder Value, Discount to NAV, Share Buyback, Investment Management Agreement